Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
Regina Beets-Tan in Mission Board for Cancer van nieuwe EU-Kaderprogramma
aug 2019 | Overig